Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04443517 · ClinicalTrials.gov registry record · NA
EEG-Guided Analgesic Titration During General Anesthesia to Improve Early Neurocognitive Recovery in Older Patients
A NA study, sponsored by Columbia University.
- Not yet
- Registry status
- NA
- Development phase
- 600
- Enrollment target
NCT04443517 is a NA study that has not yet begun recruiting, run by Columbia University. The registered enrollment target is 600 participants.
The verdict
NCT04443517, a NA study, has not yet begun recruiting, sponsored by Columbia University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
Study Summary
The investigators intend to recruit 600 participants to see if alpha power during anesthesia is influenced by analgesic medication and associated with a reduction of delirium following surgery.
Interventions
- PROCEDURE Alpha Optimization
- BEHAVIORAL Emergence from anesthesia with Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2031-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04443517
The ClinicalTrials.gov registry entry for NCT04443517 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alpha Optimization is the first listed.
NCT04443517 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04443517 about?
NCT04443517 is a clinical study titled "EEG-Guided Analgesic Titration During General Anesthesia to Improve Early Neurocognitive Recovery in Older Patients". The investigators intend to recruit 600 participants to see if alpha power during anesthesia is influenced by analgesic medication and associated with a reduction of delirium following surgery.
What is the current status of trial NCT04443517?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2026-04-01. Estimated completion is 2031-03-31.
What interventions are being tested in trial NCT04443517?
The interventions under investigation include: Alpha Optimization (PROCEDURE), Emergence from anesthesia with Dexmedetomidine (BEHAVIORAL).
Who is sponsoring clinical trial NCT04443517?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.